Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia

NCT00006136 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Beta-Thalassemia

Interventions

DRUG: arginine butyrate
DRUG: epoetin alfa

Sponsor

Boston University